The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Expression of amphiregulin (AREG) and response to first-line panitumumab (pmab) + FOLFIRI in metastatic colorectal cancer (mCRC).
 
Claus-Henning Kohne
Honoraria - Amgen; Bayer; Merck
 
Ralf D. Hofheinz
Consulting or Advisory Role - Amgen; Merck; Roche Pharma AG
Speakers' Bureau - Amgen; Merck; Roche Pharma AG
Research Funding - Amgen; Merck; Roche Pharma AG
 
Laurent Mineur
Honoraria - Amgen
Consulting or Advisory Role - Amgen
Research Funding - Amgen
 
Henry Letocha
No Relationships to Disclose
 
Richard Greil
Research Funding - Amgen
 
Josef Thaler
Honoraria - Amgen
Research Funding - Amgen
 
Brian Twomey
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Kelly Smith Oliner
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Michael Boedigheimer
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Jan-Henrik Terwey
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Meinolf Karthaus
Honoraria - Amgen; Roche Pharma AG
Consulting or Advisory Role - Amgen; Roche Pharma AG
Travel, Accommodations, Expenses - Amgen; Roche Pharma AG